Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Routine Nebulization of Mucolytics and Bronchodilators During Mechanical Ventilation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 year or older~* Expected duration of intubation and ventilation \> 24 hours~* Written informed consent~Exclusion Criteria:~* Age less than 18 years~* Ventilation before present ICU admission (though short-term ventilation in the emergency room or in the operation room for general anesthesia during surgery is allowed)~* Suspected or confirmed pregnancy~* Diagnosed with lung diseases for which inhalation therapy and/or oral steroids are used~* Diagnoses of: Guillain-Barré syndrome, complete spinal cord lesion or amyotrophic lateral sclerosis, Multiple Sclerosis, Myasthenia Gravis~* Known allergy for acetylcysteine or salbutamol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- acetylcysteine and salbutamol (Type: ACTIVE_COMPARATOR): Nebulisation of 3 mL-solution of acetylcysteine (fluimucil 100mg/ml, a mucolytic) and a 2.5 mL solution containing salbutamol (ventolin 2.5 Nebules 2.5mg/2.5 ml, a bronchodilator), administered every 6 hours (i.e., 4 times per day) within 24 hours after initiation of ventilation until tracheal extubation.
- acetylcysteine or salbutamol (Type: EXPERIMENTAL): Nebulisation on strict clinical indications; nebulisation of 3 mL-solution of acetylcysteine (fluimucil 100mg/ml, a mucolytic) in case of occurrence of persistent thick and tenacious sputum and only after active humidification is set.~Nebulisation of 2.5 mL solution containing salbutamol (ventolin 2.5 Nebules 2.5mg/2.5 ml, a bronchodilator) in case of occurrence of bronchospasm.

Based on this trial design, predict the completion outcome and termination type (if applicable).